Australian Institute of Health and Welfare (2021) Alcohol and other drug treatment services in Australia annual report., AIHW, Australian Government, accessed 01 December 2021
Australian Institute of Health and Welfare. (2021). Alcohol and other drug treatment services in Australia annual report. Retrieved from https://pp.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Alcohol and other drug treatment services in Australia annual report. Australian Institute of Health and Welfare, 16 July 2021, https://pp.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia annual report [Internet]. Canberra: Australian Institute of Health and Welfare, 2021 [cited 2021 Dec. 1]. Available from: https://pp.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Australian Institute of Health and Welfare (AIHW) 2021, Alcohol and other drug treatment services in Australia annual report, viewed 1 December 2021, https://pp.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Get citations as an Endnote file:
On this page:
In 2019–20, 23 publicly funded alcohol and other drug treatment agencies in Tasmania provided 3,715 closed treatment episodes to 2,761 clients (tables SA.1, SCR.21).
The visualisation shows that 3,715 closed treatment episodes were provided to an estimated 2,761 clients in Tasmania in 2019–20. This equates to a rate of 781 episodes and 580 clients per 100,000 population, a lower rate than the 1,064 episodes and 624 clients per 100,000 population reported nationally.
The visualisation includes a series of horizontal bar graphs showing that, in 2019–20, over 9 in 10 (93%) clients in Tasmania received treatment for their own drug use. Of these clients, two-thirds (66%) were male, 54% were aged 20–39, and 12% were Indigenous Australians. Nearly all clients (96%) listed English as their preferred language and were born in Australia (95%).
Over the period 2015–16 to 2019–20, 9,960 clients received treatment in Tasmania. Of these clients:
In 2019–20, for clients in Tasmania receiving treatment episodes for their own alcohol or drug use:
Clients can nominate up to 5 additional drugs of concern; these drugs are not necessarily the subject of any treatment within the episode (see Technical notes).
In 2019–20, when the client reported additional drugs of concern:
Over the period 2015–16 to 2019–20:
The grouped horizontal bar chart shows that, in 2019–20, alcohol was the most common principal drug of concern in treatment episodes provided to clients in Tasmania for their own drug use (40%). This was followed by amphetamines (30.1%), cannabis (19%), and morphine (1.5%). Cannabis was the most common additional drug of concern (19% of episodes), followed by amphetamines (11%), alcohol (8.1%), and nicotine (7.8%).
The line graph shows that, between 2015–16 and 2019–20, methamphetamine has remained the most common drug of concern among meth/amphetamine-related treatment episodes for clients’ own use. The proportion of methamphetamine-related episodes increased from 65% in 2015–16 to 93% in 2019–20. Conversely, there was a decrease in the proportion of episodes relating to amphetamines (from 34% to 6.6%).
The stacked horizontal bar chart shows the method of use for treatment episodes related to clients’ own use of meth/amphetamines in Tasmania in 2019–20. Injecting was the most common method of use for treatment episodes relating to amphetamine (38%), methamphetamine (52%), and other amphetamines (43%). Smoking was the second most common method of use for methamphetamine (33%) and amphetamine (26%), while ingesting (43%) was the same proportion as injecting for other amphetamines.
In 2019–20, for treatment episodes in Tasmania:
The grouped horizontal bar chart shows that, in 2019–20, the most common main treatment type provided to clients in Tasmania for their own drug use was counselling (49% of episodes). This was followed by rehabilitation (20%), assessment only (18%), and support and case management (5.4%). Counselling was also the most common additional treatment type (7.4%).
Tasmania only has the geographical classifications of Inner regional, Outer regional and Remote areas.
In 2019–20, in Tasmania:
In the 5 years to 2019–20, the number of publicly funded treatment agencies in Tasmania rose from 23 in 2015–16 to 27 in 2017–18 before falling to 23 again in 2019–20 (Table SA.1).
Note that remoteness categories are derived by applying a correspondence based on the agency’s Statistical Area level 2 code (SA2). Not all SA2 codes fit neatly within a single remoteness category, and a ratio is applied to reapportion each SA2 to the applicable remoteness categories. As a result, it is possible that the number of agencies in a particular remoteness category is not a whole number. After rounding, this can result in there being ‘<0.5%’ agencies in a remoteness area, due to the agency’s SA2 partially crossing into the remoteness area. See technical notes for further details.
The horizontal bar chart shows that Tasmania does not have any areas classified as Major cities, Remote or Very remote. Treatment agencies were located in Inner regional (15 agencies) and Outer regional (8 agencies) areas. Of the total 23 treatment agencies, most (15 agencies) were non-government agencies.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.